We’re rebranding: Innervision Media is becoming Innervision Global. Find out more →

Cindy Ng PC of DIAGNO-PHARM (Malaysia) SDN BHD Recognised with Heroes of Industry Award for Wound Care Innovation 2026

Cindy Ng PC, CEO and Co-Founder of DIAGNO-PHARM (MALAYSIA) SDN BHD, has been recognised with the Heroes of Industry Award in Wound Care Innovation 2026, celebrating her continued contribution to advancing practical, patient-focused solutions across hospitals, wound centres and home-care settings.

The recognition follows Cindy’s previous Rising Phoenix Award, with the Innervision editorial panel continuing to follow her journey and identifying wound care innovation as another significant area of her work deserving recognition.

At the heart of Cindy’s approach is a clear ambition: to redefine standards of healing while improving the everyday lives of patients.

“Our primary goal is to redefine the standards of healing and drastically improve patient quality of life through groundbreaking wound care solutions,” Cindy explains. “Ultimately, this reminds us that behind every innovation is a patient waiting to reclaim their life and independence.”

For Cindy and the team at DIAGNO-PHARM, innovation is not simply about developing new technologies. It is about translating advanced research into practical medical advancements that can create a tangible difference for patients and healthcare professionals.

That philosophy is particularly important within wound care, where chronic and complex wounds can have a significant impact on a person’s mobility, independence and overall quality of life. For Cindy, one of the greatest rewards of working within the profession is seeing scientific progress translate into meaningful human outcomes.

She describes this as “the direct, visible impact of transforming scientific breakthroughs into restored human dignity,” adding that witnessing a patient heal from a chronic condition that had previously limited their life brings a profound sense of purpose to the work.

Looking ahead, Cindy believes the next decade could fundamentally change how wounds are treated and managed. She anticipates the industry moving away from predominantly reactive treatment towards proactive, intelligent and personalised regeneration, supported by developments in biotechnology and digital health.

Traditional dressings, she believes, will increasingly be complemented by technologies such as smart dressings, real-time sensors and AI-driven diagnostics. These advances could enable complex wound management to be carried out more safely within patients’ homes, creating greater convenience while supporting a more personalised approach to care.

Remaining at the forefront of such a rapidly developing sector requires continuous learning. Cindy encourages a culture of curiosity within DIAGNO-PHARM, combined with direct engagement with frontline medical professionals. This connection between research, industry and real-world clinical experience helps ensure that innovation remains relevant to the challenges faced by healthcare professionals and patients.

The company also looks beyond simply responding to existing industry requirements. Through the early adoption of global regulatory frameworks and academic alliances, Cindy and her team aim to anticipate how healthcare will evolve and develop wound care innovations capable of meeting the expectations of regulators, clinicians and patients alike.

For those hoping to build a career in wound care innovation, Cindy believes technical knowledge must be accompanied by a genuine understanding of the people whose lives that innovation is intended to improve.

Her advice is to “master the intersection of deep empathy and rigorous data” and spend time on the frontline understanding the realities of chronic wound management.

“Fall in love with the process, not just the solution, because resiliency and interactive learning are what lead to award-winning breakthroughs. Never lose sight of human dignity.”

Through DIAGNO-PHARM (MALAYSIA) SDN BHD, Cindy continues to champion an approach to wound care in which scientific advancement, practical application and patient wellbeing work hand in hand. Her Heroes of Industry Award in Wound Care Innovation 2026 recognises not only the progress already made, but a continuing commitment to developing solutions that can help patients heal, regain independence and experience a better quality of life.

About Cindy Ng PC & DIAGNO-PHARM (MALAYSIA) SDN BHD

Cindy Ng PC is the CEO and Co-Founder of DIAGNO-PHARM (MALAYSIA) SDN BHD, where she is committed to advancing wound care through practical, innovative and patient-focused solutions. Working across hospital, wound centre and home-care settings, Cindy and her team combine research, industry knowledge and frontline insight to develop solutions designed to improve healing outcomes, patient independence and quality of life.

Contact

Phone: +60 3-9284 4168

Email: diagnoph@gmail.com

Website: diagno-pharm.com